Viral Interference of Hepatitis C and E Virus Replication in Novel Experimental Co-Infection Systems

Cells. 2022 Mar 8;11(6):927. doi: 10.3390/cells11060927.

Abstract

Background: Hepatitis C virus (HCV) constitutes a global health problem, while hepatitis E virus (HEV) is the major cause of acute viral hepatitis globally. HCV/HEV co-infections have been poorly characterized, as they are hampered by the lack of robust HEV cell culture systems. This study developed experimental models to study HCV/HEV co-infections and investigate viral interference in cells and humanized mice.

Methods: We used state-of-the art human hepatocytes tissue culture models to assess HEV and HCV replication in co- or super-transfection settings. Findings were confirmed by co- and super-infection experiments in human hepatocytes and in vivo in human liver chimeric mice.

Results: HEV was inhibited by concurrent HCV replication in human hepatocytes. This exclusion phenotype was linked to the protease activity of HCV. These findings were corroborated by the fact that in HEV on HCV super-infected mice, HEV viral loads were reduced in individual mice. Similarly, HCV on HEV super-infected mice showed reduced HCV viral loads.

Conclusion: Direct interference of both viruses with HCV NS3/4A as the determinant was observed. In vivo, we detected reduced replication of both viruses after super-infection in individual mice. These findings provide new insights into the pathogenesis of HCV-HEV co-infections and should contribute to its clinical management in the future.

Keywords: HCV protease; Hepatitis C virus (HCV); Hepatitis E virus (HEV); co-infection; human hepatocytes; human liver chimeric mice; sofosbuvir.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Coinfection*
  • Hepacivirus / genetics
  • Hepatitis C*
  • Hepatitis E virus* / genetics
  • Mice
  • Viral Interference
  • Virus Replication